Meclofenoxate

Meclofenoxate (INN, BAN; brand name Lucidril, also known as centrophenoxine) is a cholinergic nootropic used as a dietary supplement.[1][2][3] It is an ester of dimethylethanolamine (DMAE) and 4-chlorophenoxyacetic acid (pCPA).

Meclofenoxate

Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	N06BX01 (WHO)
Legal status
Legal status	US: Not FDA approved In general: ℞ (Prescription only)
Identifiers
IUPAC name 2-Dimethylaminoethyl (4-chlorophenoxy)acetate
CAS Number	51-68-3
PubChem CID	4039
ChemSpider	3899
UNII	C76QQ2I0RG
KEGG	D00993
CompTox Dashboard (EPA)	DTXSID9046940
ECHA InfoCard	100.000.107
Chemical and physical data
Formula	C12H16ClNO3
Molar mass	257.71 g·mol^−1
3D model (JSmol)	Interactive image
SMILES Clc1ccc(cc1)OCC(=O)OCCN(C)C
InChI InChI=1S/C12H16ClNO3/c1-14(2)7-8-16-12(15)9-17-11-5-3-10(13)4-6-11/h3-6H,7-9H2,1-2H3 Key:XZTYGFHCIAKPGJ-UHFFFAOYSA-N
(what is this?)  (verify)

In elderly patients, meclofenoxate has been shown to improve performance on certain memory tests.[4] Meclofenoxate also increases cellular membrane phospholipids. It is sold in Japan and some European countries, such as Germany, Hungary, and Austria, as a prescription drug.[3]

Side effects

Meclofenoxate is considered to be very safe and high in tolerability.[3] However, possible side effects may include, rarely, insomnia, dizziness, restlessness, muscle tremor, depression, nausea, muscle tension, and headache; these side effects may be due to overdosage and may indicate the need for the dosage to be reduced.[3]

Research

Meclofenoxate, as well as DMAE, have been found to increase the lifespans of mice by 30–50%.[5]

Brand names

In addition to Lucidril, meclofenoxate has also been marketed under the brand names Amipolen, Analux, Brenal, Cellative, Centrophenoxin, Cerebron, Cerutil, Closete, Helfergin, Lucidryl, Lutiaron, Marucotol, Proserout, Proseryl, and Ropoxyl.[6]

See also

• Adafenoxate
• Cyprodenate

References

1. Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 758–. ISBN 978-1-4757-2085-3.
2. Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 636–. ISBN 978-3-88763-075-1.
3. Haavisto M (1 May 2008). Reviving the Broken Marionette: Treatments for CFS/ME and Fibromyalgia. Lulu.com. pp. 167–. ISBN 978-1-4092-0335-3.
4. Marcer D, Hopkins SM (May 1977). "The differential effects of meclofenoxate on memory loss in the elderly". Age and Ageing. 6 (2): 123–31. doi:10.1093/ageing/6.2.123. PMID 329662.
5. Donaldson T (1 January 2003). "A Brief History of Anti-aging Drugs". In Klatz R, Goldman B (eds.). The Science of Anti-aging Medicine. American Academy of Anti-Aging Med. pp. 66–. ISBN 978-0-9668937-3-1.
6. Zhou Y (22 October 2013). Drugs in Psychiatric Practice. Elsevier. ISBN 978-1-4831-9193-5.